CCP puts patient benefit over patient choice in acute merger

By Ben Clover2011-09-30T16:40:00

The Co-operation and Competition Panel has advised, for the first time, that a merger between two rival providers can go ahead, because the potential benefits outweighed the reduction in patient choice.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here